Sustained Clinical Benefit Seen for Pembrolizumab + Axitinib in Advanced Renal Cancer

FRIDAY, Aug. 8, 2025 (HealthDay News) -- For patients with advanced renal cell carcinoma (RCC), there is a sustained clinical benefit with pembrolizumab plus ax